Heparin Injection Market Definition
Heparin is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to prevent and treat blood clots in the lungs/legs or any other part of the body. It is also used to treat certain blood clotting disorders. It can be used to prevent blood clots after surgery, during dialysis, during blood transfusion, during collection of blood samples or when person is unable to move for long time.
The market study is broken down by Type (1,000 USP/mL, 5,000 USP/mL, 10,000 USP/mL and 20,000 USP/mL), by Application (Thrombosis,, Pulmonary Embolism, Hemodialysis and Others) and major geographies with country level splits.
Pfizer Inc (United States), Wellona Pharma (India), B. Braun (Germany), Gland Pharma Limited (India), Sagent Pharmaceuticals, Inc. (United States), Mylan (United States), Rewine Pharmaceutical (India) and Shenzhen Techdow Pharmaceutical Co., Ltd (China) are some of the key players that are part of study coverage.
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Heparin Injection market by Type, Application and Region.
On the basis of geography, the market of Heparin Injection has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Heparin Type, the sub-segment i.e. Unfractionated Heparin, will boost the Heparin Injection market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Ingredients, the sub-segment i.e. Sodium will boost the Heparin Injection market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Source, the sub-segment i.e. Bovine will boost the Heparin Injection market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Leaders and their expansionary development strategies
In July 2019, B. Braun has acquired Nephtec with the takeover of the business operations of Nephtec GmbH, B. Braun Avitum AG, as a systems provider for extracorporeal blood treatment (dialysis), has strengthened its product portfolio in the area of the central preparation of dialysis concentrates.
In March 2019, B. Braun Medical Inc. has launched its Heparin Sodium Injection, USP, he first Heparin 5,000 USP Unit / 0.5 mL prefilled syringe with attached safety needle for subcutaneous and intravenous use in the United States. The company continues to develop products designed to increase patient and clinician safety, while reducing medication errors and improving dosage accuracy and workflows
Market Trend
- High Demand for Effective Blood Thiners
Market Drivers
- Increased Prevalence of Diseases such as Thrombosis and Pulmonary Embolism
- Increased number of Hospitals and Clinics
Opportunities
- Increasing Awareness Regarding the Treatment
- Growing Number of Online Pharmacies
Restraints
- Side Effects of the Drugs
Challenges
- Lack of Proper Diagnosis
- Less Awareness among the People in Developing Countries
Key Target Audience
Heparin Injection Providers, Distributors, Research Professionals and End-users
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase